Is bleeding when brushing teeth leukemia?

Written by Li Bao Hua
Dentistry
Updated on September 05, 2024
00:00
00:00

Bleeding during brushing is not necessarily leukemia; it could also be due to gingivitis or periodontitis. Bleeding can occur around the teeth where there are irritants like soft plaque or dental plaque. These irritants chronically stimulate the gingival tissues, causing them to be in a congested state. A stimulus, such as brushing, can then lead to bleeding of the gums. This condition is a common early sign of gingivitis or periodontitis. After dental cleaning to remove these irritants, followed by rinsing and medicating the area around the gums, the condition of gingivitis can be improved. Therefore, if bleeding during brushing can be improved through dental cleaning and medication, it indicates that the bleeding is simply caused by gingivitis or periodontitis, and not leukemia.

Other Voices

doctor image
home-news-image
Written by Li Fang Fang
Hematology
53sec home-news-image

Symptoms of Acute Leukemia

The common symptoms of acute leukemia include four main categories: infection, anemia, bleeding, and tumor infiltration. Symptoms of infection manifest as fever, cough, expectoration, chest pain, abdominal pain, diarrhea, frequent urination, urgent urination, painful urination, skin infections, and perianal infections. Anemia is characterized by dizziness, fatigue, poor appetite, and decreased endurance. Symptoms of reduced platelets mainly involve bleeding, which can manifest as bleeding of the skin and mucous membranes, organ bleeding, and even cerebral hemorrhage. Tumor infiltration can manifest as gingival hyperplasia and skin rashes among other swellings.

doctor image
home-news-image
Written by Li Fang Fang
Hematology
1min 3sec home-news-image

What are the symptoms of leukemia?

The symptoms of leukemia mainly fall into four categories: infections, anemia, bleeding, and tumor infiltration. Infections occur because the proliferation of leukemia cells leads to a reduction in the patient's own granulocytes, lowering their resistance and possibly leading to various secondary infections such as respiratory, urinary system, and skin mucous membrane infections. Anemia is due to the proliferation of leukemia cells, which restricts normal erythropoiesis in the bone marrow, leading to symptoms in patients such as dizziness, headaches, fatigue, and decreased stamina. Bleeding occurs due to a decrease in platelets, posing a risk of spontaneous bleeding, which can include bleeding of the skin mucous membranes, organs, and even cerebral hemorrhage. Tumor infiltration by leukemia cells may manifest as tumor masses on the skin surface.

doctor image
home-news-image
Written by He Li Fang
Hematology
53sec home-news-image

Causes of Chronic Myeloid Leukemia

Chronic granulocytic leukemia, also known as chronic myeloid leukemia, is a myeloproliferative tumor originating from pluripotent stem cells. It is characterized by a specific chromosomal alteration, commonly referred to as the Philadelphia chromosome, which is formed by the translocation of chromosomes 9 and 22, resulting in the formation of the BCR-ABL fusion gene at the molecular level. Chronic granulocytic leukemia is a clonal disease originating from pluripotent stem cells. Due to a significant expansion of the progenitor cell pool, there is excessive proliferation of myeloid cells and increased granulocyte production. The slow clearance of granulocytes leads to the accumulation of granulocytes in the body, which is the main cause of the disease.

doctor image
home-news-image
Written by He Li Fang
Hematology
1min 56sec home-news-image

Chronic granulocytic leukemia etiology

Chronic granulocytic leukemia is a myeloproliferative tumor originating from multipotent stem cells. It is characterized by the translocation of chromosomes 9 and 22 forming the BCR/ABL fusion gene. The Philadelphia chromosome is a characteristic change in chronic granulocytic leukemia, first discovered and named in Philadelphia in 1960. Initially, it was observed as a deletion of the long arm of the primary chromosome in dividing blood cells of patients with this leukemia. Currently, studies have shown that abnormalities in the interaction between hematopoietic progenitor cells and the stroma might be central to treating the disease. Abnormal adhesion and anchoring characteristics of progenitor cells lead to disrupted cell maturation and proliferation. Chronic granulocytic cells do not adhere to stromal cells as normal cells do, particularly lacking integrin-mediated adhesion. Additionally, the expression of the adhesion molecule lymphocyte function-associated antigen 3 is also reduced in these cells. Therefore, the progression of the disease results from clonal changes. During the transformation of chronic granulocytic leukemia to acute myeloid leukemia, there is an increased rate of genetic mutations. Changes in gene expression during the progression involve various aspects, including nucleosome sugar metabolism, bone marrow myeloid differentiation, genomic instability of cell apoptosis genes, and processes related to DNA damage repair.

doctor image
home-news-image
Written by He Li Fang
Hematology
1min 16sec home-news-image

chronic granulocytic leukemia course

The course of chronic granulocytic leukemia is relatively long, as it is a type of chronic leukemia. Its onset is gradual, and its natural course includes four stages: asymptomatic phase, chronic phase, accelerated phase, and blast crisis phase. Most patients seek medical attention and are diagnosed only after symptoms appear, with very few patients discovering blood abnormalities during physical examinations or blood tests conducted for other reasons. At this point, the spleen may already be mildly enlarged, or not enlarged at all. In the early stages of the disease, some patients may experience an absolute increase in basophilic granulocytes. When the white blood cell count is less than 20×10^9/L, there is a decrease in neutrophil alkaline phosphatase activity in peripheral blood, and this decreases further as the disease progresses. When the white blood cell count exceeds 40×10^9/L, the spleen can be felt below the ribs. Between 30 and 90×10^9/L, a range of related clinical symptoms may appear.